The Biology department of Medicilon has an extensive experience in molecular biology, cell biology, in vitro biology and structural biology.
Our structural biology department offers services supporting structure-based drug discovery from determination of novel targets to final structures. Our platform is one of the earliest established structural biology platforms in China and has been certified by the Shanghai Government.
Medicilon's team integrates expertise in Kinase Services with deep knowledge of regulatory, market access and commercial global pathways. This service was designed to meet your specific needs fast at extremely competitive prices. We can also provide screening services on specified signaling pathways areas in accordance to your needs.